● Pharmacogenetics
-
Tib neeg CYP2C9 thiab VKORC1 Gene Polymorphism
Cov khoom siv no siv tau rau hauv vitro qualitative nrhiav pom ntawm polymorphism ntawm CYP2C9 * 3 (rs1057910, 1075A>C) thiab VKORC1 (rs9923231, -1639G>A) hauv genomic DNA ntawm tib neeg cov ntshav kuaj.
-
Tib neeg CYP2C19 Gene Polymorphism
Cov khoom siv no yog siv rau hauv vitro qualitative nrhiav tau ntawm polymorphism ntawm CYP2C19 noob CYP2C19 * 2 (rs4244285, c.681G>A), CYP2C19 * 3 (rs4986893, c.636G>A), CYP2C19, CYP2C19 * 1. > T) hauv genomic DNA ntawm tib neeg cov ntshav kuaj.
-
Tib neeg Leukocyte Antigen B27 Nucleic Acid
Cov khoom siv no yog siv rau kev kuaj pom zoo ntawm DNA hauv tib neeg leukocyte antigen subtypes HLA-B * 2702, HLA-B * 2704 thiab HLA-B * 2705.
-
MTHFR Gene Polymorphic Nucleic Acid
Cov khoom siv no yog siv los txheeb xyuas 2 qhov chaw hloov pauv ntawm MTHFR noob.Cov khoom siv siv tib neeg cov ntshav tag nrho los ua cov qauv kuaj kom muaj kev ntsuam xyuas zoo ntawm kev hloov pauv.Nws tuaj yeem pab cov kws kho mob txhawm rau tsim cov phiaj xwm kho mob tsim nyog rau tus kheej cov yam ntxwv sib txawv los ntawm qib molecular, txhawm rau ua kom muaj kev noj qab haus huv ntawm cov neeg mob mus rau qhov loj tshaj plaws.
